β οΈ The physician must carefully balance the risks of persistent hyponatraemia against the dangers of rapid correction.
π― High-risk groups: patients with hypoxia, alcoholism, liver disease, or severe malnutrition.
π§ Central Pontine Myelinolysis (Osmotic Demyelination Syndrome)
- First described in 1956, CPM is characterised by demyelination within the central pons due to rapid electrolyte shifts.
- Most often triggered by overly fast correction of chronic hyponatraemia.
- Despite being non-inflammatory, the syndrome can cause devastating, often irreversible neurological deficits.
β οΈ Aetiology
- Rapid correction of chronic hyponatraemia (especially with hypertonic saline).
- Pathophysiology: as sodium rises quickly, osmotic forces draw water out of swollen CNS cells β dehydration β oligodendrocyte injury and myelin destruction.
- Other causes: severe hypernatraemia correction, liver transplantation, chronic alcoholism, profound malnutrition.
π Risk Factors
- Chronic alcohol dependence πΊ
- Malnutrition/cachexia π½οΈ
- Liver disease or postβliver transplant π₯
- Initial sodium <120 mmol/L for >48h β³
- Overcorrection: >12 mmol/L in 24h or >18 mmol/L in 48h π«
π©Ί Clinical Features
- Progressive quadriparesis β quadriplegia.
- Brainstem involvement:
- Dysarthria (slurred speech)
- Dysphagia (difficulty swallowing)
- Ophthalmoplegia with bilateral pinpoint pupils ποΈ
- Cognitive/behavioural: delirium, confusion, reduced consciousness.
- Classic exam clue: intact corneal reflexes despite severe deficits.
- Fever may mislead towards infection.
π Differential Diagnosis
- Brainstem stroke π§
- Brainstem encephalitis (e.g. Listeria)
- Tetanus or meningitis
- Drug toxicity/overdose
- Seizure-related: post-ictal state, non-convulsive status epilepticus
π§ͺ Investigations
- Bloods: FBC, U&E, LFTs, clotting; look for chronic liver disease, alcohol misuse, malnutrition.
- CSF: Often non-diagnostic; may show β protein.
- MRI (preferred):
- T2 hyperintense lesion in central pons β classic "bat-wing" or "trident" sign π¦
- May extend into thalamus, midbrain, medulla or cerebellum.
π Management
- Prevention is key β
:
- Correct sodium slowly: <10β12 mmol/L in 24h, <18 mmol/L in 48h.
- In very high-risk groups (alcoholic, malnourished): aim even lower (β€8 mmol/L per 24h).
- Close monitoring: Frequent serum sodium checks (every 2β4h during correction).
- Supportive therapy:
- Neurorehab, physiotherapy π
- Speech therapy for dysphagia π£οΈ
- Nutritional support and alcohol cessation counselling.
- Outcome: Some recovery possible, especially with rehab, but severe cases may leave permanent disability.
π Prognosis
- Mild cases: partial recovery possible with rehab.
- Severe cases: persistent locked-inβlike state or death.
- Emphasis: slow correction saves lives.
π References
- Verbalis JG, et al. (2013). Hyponatremia treatment guidelines 2013. Am J Med.
- Martin RJ. (2004). Central Pontine and Extrapontine Myelinolysis: The osmotic demyelination syndromes. J Neurol Neurosurg Psychiatry.
- NICE CG174: Hyponatraemia Management, 2020 update.